Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03067779 · ClinicalTrials.gov registry record · NA
Is There a Digital Divide in Chronic Kidney Disease (CKD)?
A NA study of Chronic Kidney Disease, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 580
- Enrollment target
- 4
- Study locations
NCT03067779: Completed NA study of Chronic Kidney Disease, sponsored by Duke University.
NCT03067779 is a NA study of Chronic Kidney Disease that has completed, run by Duke University. The registered enrollment target is 580 participants, below the 3,201-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (82% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03067779, a NA study of Chronic Kidney Disease, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 580 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is looking to improve the safety of patients with chronic kidney disease via education provided on a mobile tablet. This study will additionally examine if electronic tools, such as mobile tablets, can help.
Primary Outcome
eHealth Literacy questionnaire and how that relates to medication errors
Conditions Studied
Interventions
- OTHER mHealth Tool
Study Locations (4)
Maryland
- University of Maryland, Baltimore - Baltimore
- Johns Hopkins University - Baltimore
North Carolina
- Duke University School of Medicine - Durham
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 580 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2018-07-30 |
| Phase | NA |
What the finished NCT03067779 record still lists
NCT03067779 is an interventional study that assigns participants to a tested intervention. The registered 580 participants enrollment target is mid-sized for trials with a published cap, below the 3,201-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which mHealth Tool is the first listed.
NCT03067779 reports a single indexed study location in Maryland, North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03067779 about?
NCT03067779 is a clinical study titled "Is There a Digital Divide in Chronic Kidney Disease (CKD)?". This study is looking to improve the safety of patients with chronic kidney disease via education provided on a mobile tablet. This study will additionally examine if electronic tools, such as mobile tablets, can help.
What is the current status of trial NCT03067779?
This trial is currently completed. It is a NA study. The enrollment target is 580 participants. The study started on 2017-06-26. Estimated completion is 2018-07-30.
What conditions does trial NCT03067779 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
What interventions are being tested in trial NCT03067779?
The interventions under investigation include: mHealth Tool (OTHER).
Who is sponsoring clinical trial NCT03067779?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03067779 being conducted?
This trial has 4 study locations across Maryland, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03067779's enrollment target sits among peer trials
580 25th of 101 higher than 77 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
-
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
RECRUITING · NA
-
Transforming Hemodialysis-Related Vascular Access Education
RECRUITING · NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
- NCT06578104 · 580 participants
PULSED AF Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI